Cybin announces fda investigational new drug and institutional review board approvals for a co-funded phase 2 clinical trial to treat frontline clinicians experiencing covid-related distress

Toronto--(business wire)--cybin announces fda investigational new drug approval for phase 2 clinical trial for frontline clinicians experiencing covid-related distress
CYBN Ratings Summary
CYBN Quant Ranking